Macrophage Migration Inhibitory Factor Mediates Neuroprotective Effects by Regulating Inflammation, Apoptosis and

Siying Li1, Kun Nie2, Qingxi Zhang2

  • 1The Second School of Clinical Medicine, Southern Medical University, No.1023, South Shatai Road, Baiyun District, Guangzhou, 510515, PR China.

Neuroscience
|June 7, 2019
PubMed

Insights

Macrophage migration inhibitory factor (MIF) shows neuroprotective effects in Parkinson's disease (PD) models. Upregulating MIF suppresses inflammation, reduces apoptosis, and enhances autophagy, offering a potential therapeutic strategy for PD.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Neuroinflammation plays a critical role in Parkinson's disease (PD) pathogenesis, but its precise influence remains unclear.
  • Macrophage migration inhibitory factor (MIF) is a key cytokine implicated in inflammatory and immune responses.

Purpose of the Study:

  • To investigate the potential neuroprotective effects of MIF in Parkinson's disease.
  • To elucidate the mechanisms by which MIF influences cellular apoptosis, mitochondrial function, and autophagy in PD models.

Main Methods:

  • Utilized RT-qPCR, FACS, and Western blotting to assess cellular apoptosis and protein expression (MIF, cleaved-PARP, LC3B-II).
  • Measured mitochondrial membrane potential (MMP) using JC-1 staining.
  • Analyzed autophagosome formation and autophagic flux via Western blot and mRFP-GFP-LC3 fluorescence microscopy.

Main Results:

  • MIF expression was elevated in PD models and positively correlated with IL-10, inversely with TNF-α.
  • Upregulating MIF reduced apoptosis (decreased cleaved-PARP) and increased MMP compared to controls.
  • MIF upregulation enhanced autophagy, evidenced by increased LC3B-II and LC3 puncta.

Conclusions:

  • MIF exhibits significant neuroprotective effects in Parkinson's disease.
  • MIF mediates these effects by suppressing inflammatory responses, inhibiting apoptosis, and promoting autophagy.
  • Targeting MIF represents a promising therapeutic avenue for Parkinson's disease treatment.